GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy.
Kasiewicz LN, Biswas S, Beach A, Ren H, Dutta C, Mazzola AM, Rohde E, Chadwick A, Cheng C, Garcia SP, Iyer S, Matsumoto Y, Khera AV, Musunuru K, Kathiresan S, Malyala P, Rajeev KG, Bellinger AM.
Kasiewicz LN, et al. Among authors: garcia sp.
Nat Commun. 2023 May 15;14(1):2776. doi: 10.1038/s41467-023-37465-1.
Nat Commun. 2023.
PMID: 37188660
Free PMC article.